AR012187A1 - Composicion farmaceutica libre de lactosa que contiene noratemizol como agente activo, formas de dosificacion que contiene dicha composicion y metodopara el tratamiento de desordenes alergicos con aplicacion de dicha composicion - Google Patents
Composicion farmaceutica libre de lactosa que contiene noratemizol como agente activo, formas de dosificacion que contiene dicha composicion y metodopara el tratamiento de desordenes alergicos con aplicacion de dicha composicionInfo
- Publication number
- AR012187A1 AR012187A1 ARP980101398A ARP980101398A AR012187A1 AR 012187 A1 AR012187 A1 AR 012187A1 AR P980101398 A ARP980101398 A AR P980101398A AR P980101398 A ARP980101398 A AR P980101398A AR 012187 A1 AR012187 A1 AR 012187A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- treatment
- noratemizol
- active agent
- dosage forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82447797A | 1997-03-26 | 1997-03-26 | |
| US85178697A | 1997-05-06 | 1997-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012187A1 true AR012187A1 (es) | 2000-09-27 |
Family
ID=27124816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980101398A AR012187A1 (es) | 1997-03-26 | 1998-03-26 | Composicion farmaceutica libre de lactosa que contiene noratemizol como agente activo, formas de dosificacion que contiene dicha composicion y metodopara el tratamiento de desordenes alergicos con aplicacion de dicha composicion |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1035869A1 (de) |
| JP (1) | JP2002512614A (de) |
| KR (1) | KR20010005746A (de) |
| CN (1) | CN1257431A (de) |
| AR (1) | AR012187A1 (de) |
| BR (1) | BR9808428A (de) |
| CA (1) | CA2284705A1 (de) |
| HU (1) | HUP0001823A3 (de) |
| NO (1) | NO994655L (de) |
| NZ (3) | NZ517472A (de) |
| RU (1) | RU2214245C2 (de) |
| WO (1) | WO1998042379A2 (de) |
| ZA (1) | ZA982562B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20002567A3 (cs) * | 2000-07-11 | 2001-12-12 | Léčiva, A.S. | Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby |
| EP2201982A1 (de) * | 2008-12-24 | 2010-06-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Histamin-H4-Rezeptorantagonisten zur Behandlung von Vestibularisstörungen |
| EA201270309A1 (ru) * | 2009-08-24 | 2012-07-30 | Абды Ибрахым Иладж Санайи Ве Тыджарет Аноным Сыркеты | Таблетки отилония, полученные прямым прессованием |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2052544T3 (es) * | 1986-02-03 | 1994-07-16 | Janssen Pharmaceutica Nv | Composiciones anti-histaminicas que contienen n-heterociclil-4-piperidinaminas. |
| DE4037426A1 (de) * | 1990-11-24 | 1992-05-27 | Kali Chemie Pharma Gmbh | Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE69333387T2 (de) * | 1992-09-03 | 2004-12-09 | Sepracor Inc., Marlborough | Pharmazeutische Zusammensetzungen enthaltend Norastemizol. |
| JPH11513991A (ja) * | 1995-11-17 | 1999-11-30 | ヘキスト・マリオン・ルセル・インコーポレイテツド | アレルギー性疾患の治療に有用な置換４−（１ｈ−ベンズイミダゾル−２−イル−アミノ）ピペリジン |
| AU722040B2 (en) * | 1996-08-16 | 2000-07-20 | Schering Corporation | Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
-
1998
- 1998-03-25 NZ NZ517472A patent/NZ517472A/en unknown
- 1998-03-25 KR KR1019997008817A patent/KR20010005746A/ko not_active Application Discontinuation
- 1998-03-25 HU HU0001823A patent/HUP0001823A3/hu unknown
- 1998-03-25 NZ NZ527201A patent/NZ527201A/xx unknown
- 1998-03-25 JP JP54589398A patent/JP2002512614A/ja active Pending
- 1998-03-25 CA CA002284705A patent/CA2284705A1/en not_active Abandoned
- 1998-03-25 EP EP98914283A patent/EP1035869A1/de not_active Withdrawn
- 1998-03-25 NZ NZ52720098A patent/NZ527200A/xx unknown
- 1998-03-25 BR BR9808428-3A patent/BR9808428A/pt not_active IP Right Cessation
- 1998-03-25 RU RU99122607/14A patent/RU2214245C2/ru not_active IP Right Cessation
- 1998-03-25 CN CN98805457A patent/CN1257431A/zh active Pending
- 1998-03-25 WO PCT/US1998/005701 patent/WO1998042379A2/en not_active Application Discontinuation
- 1998-03-26 ZA ZA982562A patent/ZA982562B/xx unknown
- 1998-03-26 AR ARP980101398A patent/AR012187A1/es unknown
-
1999
- 1999-09-24 NO NO994655A patent/NO994655L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA982562B (en) | 1998-10-01 |
| RU2214245C2 (ru) | 2003-10-20 |
| NZ517472A (en) | 2003-08-29 |
| AU6868098A (en) | 1998-10-20 |
| AU735257B2 (en) | 2001-07-05 |
| HUP0001823A2 (hu) | 2001-04-28 |
| WO1998042379A2 (en) | 1998-10-01 |
| NO994655D0 (no) | 1999-09-24 |
| CA2284705A1 (en) | 1998-10-01 |
| WO1998042379A3 (en) | 2001-03-01 |
| JP2002512614A (ja) | 2002-04-23 |
| HUP0001823A3 (en) | 2002-04-29 |
| NZ527200A (en) | 2004-12-24 |
| NO994655L (no) | 1999-11-15 |
| NZ527201A (en) | 2004-12-24 |
| BR9808428A (pt) | 2000-05-23 |
| KR20010005746A (ko) | 2001-01-15 |
| EP1035869A1 (de) | 2000-09-20 |
| CN1257431A (zh) | 2000-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR046933A1 (es) | Eficacia de humectacion mejorada mediante el uso de hidroxialquilurea | |
| CY1107925T1 (el) | Διαλυμα για εφαρμογη στα νυχια | |
| CL2008002407A1 (es) | Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04). | |
| BRPI0513864A (pt) | compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, sua utilização e método para o tratamento e/ou profilaxia de enfermidades | |
| MX9202407A (es) | Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion. | |
| SE0102438D0 (sv) | New compounds | |
| AR053541A1 (es) | Combinacion de xolair con agente inmunosupresor | |
| CO4440476A1 (es) | Composicion sinergistica que comprende una combinacion plaguicida de ingredientes activos . | |
| BR9814923A (pt) | Método para tratamento de doença de alzheimer | |
| DE60134245D1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
| AR034900A1 (es) | Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica | |
| ES2421948T3 (es) | Compuestos y composiciones para suministrar agentes activos | |
| FI964285A (fi) | Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet | |
| ATE287267T1 (de) | Kombinationstherapien mit gefässschädigender aktivität | |
| ECSP034826A (es) | Método para fabricar una composición farmacéutica de dosis baja | |
| SE9802208D0 (sv) | Novel compounds | |
| BR9809022A (pt) | Composições antiinflamatórias nasais tópicas | |
| AR029456A1 (es) | Forma triturada | |
| FR2816507B1 (fr) | Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules | |
| BR0306732A (pt) | Tratamentos em combinação para doença alérgica compreendendo a administração de um anticorpo anti-ige e composto antialérgico | |
| DK1280558T3 (da) | Halvfast indgivelsesvehikel og farmaceutiske sammensætninger | |
| AR012187A1 (es) | Composicion farmaceutica libre de lactosa que contiene noratemizol como agente activo, formas de dosificacion que contiene dicha composicion y metodopara el tratamiento de desordenes alergicos con aplicacion de dicha composicion | |
| SE9802209D0 (sv) | Novel compounds | |
| ES2150404T3 (es) | Composiciones farmaceuticas de tizoxanida y nitozoxanida. | |
| CO5261624A1 (es) | Novedosos derivados fenilheteroalquilamina, procesos para su preparacion, composiciones farmaceuticas que comprenden dichos derivados novedosos y su uso en terapia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |